The global market for Antisense and RNAi Therapeutics estimated at US$ 1.2 Billion in the year 2020, is projected to reach a revised size of US$ 1.9 Billion by 2027, growing at a CAGR of 6% over the period 2021-2027. Antisense and RNAi therapeutics are a new class of drugs that work by silencing parts […]
